Literature DB >> 30913199

ACOG Committee Opinion No. 774: Opportunistic Salpingectomy as a Strategy for Epithelial Ovarian Cancer Prevention.

.   

Abstract

Opportunistic salpingectomy may offer obstetrician-gynecologists and other health care providers the opportunity to decrease the risk of ovarian cancer in their patients who are already undergoing pelvic surgery for benign disease. By performing salpingectomy when patients undergo an operation during which the fallopian tubes could be removed in addition to the primary surgical procedure (eg, hysterectomy), the risk of ovarian cancer is reduced. Although opportunistic salpingectomy offers the opportunity to significantly decrease the risk of ovarian cancer, it does not eliminate the risk of ovarian cancer entirely. Counseling women who are undergoing routine pelvic surgery about the risks and benefits of salpingectomy should include an informed consent discussion about the role of oophorectomy and bilateral salpingo-oophorectomy. Bilateral salpingo-oophorectomy that causes surgical menopause reduces the risk of ovarian cancer but may increase the risk of cardiovascular disease, cancer other than ovarian cancer, osteoporosis, cognitive impairment, and all-cause mortality. Salpingectomy at the time of hysterectomy or as a means of tubal sterilization appears to be safe and does not increase the risk of complications such as blood transfusions, readmissions, postoperative complications, infections, or fever compared with hysterectomy alone or tubal ligation. The risks and benefits of salpingectomy should be discussed with patients who desire permanent sterilization. Additionally, ovarian function does not appear to be affected by salpingectomy at the time of hysterectomy based on surrogate serum markers or response to in vitro fertilization. Plans to perform an opportunistic salpingectomy should not alter the intended route of hysterectomy. Obstetrician-gynecologists should continue to observe and practice minimally invasive techniques. This Committee Opinion has been updated to include new information on the benefit of salpingectomy for cancer reduction, the feasibility of salpingectomy during vaginal hysterectomy, and long-term follow-up of women after salpingectomy.

Entities:  

Mesh:

Year:  2019        PMID: 30913199     DOI: 10.1097/AOG.0000000000003164

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  15 in total

1.  Variation in the interpretation and application of the Medicaid sterilization consent form among Medicaid officials.

Authors:  Colin B Russell; Neena Qasba; Megan L Evans; Angela Frankel; Kavita Shah Arora
Journal:  Contraception       Date:  2022-01-14       Impact factor: 3.051

2.  Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.

Authors:  Pritesh S Karia; Yongmei Huang; Parisa Tehranifar; Kala Visvanathan; Jason D Wright; Jeanine M Genkinger
Journal:  Am J Obstet Gynecol       Date:  2022-04-27       Impact factor: 10.693

3.  Moving Beyond Reflexive and Prophylactic Gynecologic Surgery.

Authors:  Elizabeth A Stewart; Stacey A Missmer; Walter A Rocca
Journal:  Mayo Clin Proc       Date:  2021-02       Impact factor: 11.104

4.  Premature or early bilateral oophorectomy: a 2021 update.

Authors:  W A Rocca; M M Mielke; L Gazzuola Rocca; E A Stewart
Journal:  Climacteric       Date:  2021-03-15       Impact factor: 3.024

Review 5.  Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.

Authors:  Jonathan S Berek; Malte Renz; Sean Kehoe; Lalit Kumar; Michael Friedlander
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

6.  Endometriosis-Associated Ovarian Cancer: The Origin and Targeted Therapy.

Authors:  Kosuke Murakami; Yasushi Kotani; Hidekatsu Nakai; Noriomi Matsumura
Journal:  Cancers (Basel)       Date:  2020-06-24       Impact factor: 6.639

Review 7.  Diagnosis and Management of Adenocarcinoma in Situ: A Society of Gynecologic Oncology Evidence-Based Review and Recommendations.

Authors:  Deanna Teoh; Fernanda Musa; Ritu Salani; Warner Huh; Edward Jimenez
Journal:  Obstet Gynecol       Date:  2020-04       Impact factor: 7.623

8.  Prophylactic salpingectomy for prevention of ovarian cancer at the time of elective laparoscopic cholecystectomy.

Authors:  G Tomasch; M Lemmerer; S Oswald; S Uranitsch; C Schauer; A-M Schütz; B Bliem; A Berger; P F J Lang; G Rosanelli; F Ronaghi; J Tschmelitsch; S F Lax; S Uranues; K Tamussino
Journal:  Br J Surg       Date:  2020-03-04       Impact factor: 6.939

9.  Variation by state in Medicaid sterilization policies for physician reimbursement.

Authors:  Heather Bouma-Johnston; Roselle Ponsaran; Kavita Shah Arora
Journal:  Contraception       Date:  2020-12-28       Impact factor: 3.375

10.  Comparing options for females seeking permanent contraception in high resource countries: a systematic review.

Authors:  Rebecca Gormley; Brian Vickers; Brooke Cheng; Wendy V Norman
Journal:  Reprod Health       Date:  2021-07-20       Impact factor: 3.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.